Received May 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | UNK | — | — |
Patient also felt tired and general malaise for approximately 24 hours after the injection.; she had received CAPVAXIVE vaccine and experienced swelling and redness in her arm where the injection occurred. Patient also had some head and warmth in the arm at the injection site.; she had received CAPVAXIVE vaccine and experienced swelling and redness in her arm where the injection occurred. Patient also had some head and warmth in the arm at the injection site.; she had received CAPVAXIVE vaccine and experienced swelling and redness in her arm where the injection occurred. Patient also had some head and warmth in the arm at the injection site.; Patient also felt tired and general malaise for approximately 24 hours after the injection.; This spontaneous report was received from a pharmacist and refers to a female patient of unknown age (also reported as older than 50). The patient's medical history, concurrent conditions, concomitant therapies, previous drug reactions and allergies were not reported. On an unknown date, the patient was vaccinated with a dose of Pneumococcal 21-valent Conjugate Vaccine Injection (CAPVAXIVE) injection, administered as prophylaxis, strength reported as: 168 mcg/ ml (Lot No., expiration date, dose number, exact dose quantity volume, route and anatomical location of administration and vaccination scheme frequency). On an unknown date, the patient experienced swelling and redness in her arm where the injection occurred (vaccination site swelling) (vaccination site erythema); had some head and warmth in the arm at the injection site (vaccination site warmth) and felt tired and general malaise for approximately 24 hours after the injection (fatigue) (malaise). On an unknown date, the patient recovered from all the events. The causal relationship between all the events with the suspect vaccine was not provided.